Managing Pediatric ADHD with Viloxazine
Theresa R. Cerulli, MD: Viloxazine is...a novel agent that is a serotonin-norepinephrine modulating agent...In children and adolescents who do have comorbid conditions, my thought is moving Qelbree, or viloxazine, to more of a first-line agent. That’s because of the pharmacodynamics of this drug.
Other Articles in this Edition
For CFOs, ADHD can be a curse and a blessing
5 Steps to Building a Supportive and Inclusive Workplace for Neurodiverse Employees
What to Do When You Can’t Afford ADHD Coaching
What are the long-term effects of ADHD medication?
1 in 5 College Students Abuse ADHD Medication— Here’s What We Can Do About It